Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2). (Q48335500)

From Wikidata

Jump to navigation Jump to search

scientific article published on 16 October 2012

Language	Label	Description	Also known as
English	Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).	scientific article published on 16 October 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2). (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

0 references

0 references

major depressive disorder

1 reference

based on heuristic

inferred from title

author name string

Tsuyoshi Nogami

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Harumasa Takano

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Ryosuke Arakawa

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Tetsuya Ichimiya

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Hironobu Fujiwara

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Yasuyuki Kimura

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Fumitoshi Kodaka

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Takeshi Sasaki

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Keisuke Takahata

9

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Masayuki Suzuki

10

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Tomohisa Nagashima

11

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Takaaki Mori

12

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Hitoshi Shimada

13

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Hajime Fukuda

14

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Mizuho Sekine

15

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Amane Tateno

16

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Hidehiko Takahashi

17

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Hiroshi Ito

18

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Yoshiro Okubo

19

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Tetsuya Suhara

20

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

publication date

16 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

The International Journal of Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

16

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

937-943

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Age-related decline of serotonin transporters in living human brain of healthy males

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Imaging the norepinephrine transporter in humans with (S,S)-[11C]O-methyl reboxetine and PET: problems and progress.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Controlled comparison of two different doses of milnacipran in major depressive outpatients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

A dose-finding study of duloxetine based on serotonin transporter occupancy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

21 January 2018

SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission rates with milnacipran 100 mg/day and 150 mg/day in the long-term treatment of major depression

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

7 January 2021

based on heuristic

inferred from DOI database lookup

Pooling two controlled comparisons of milnacipran (F2207) and amitriptyline in endogenous inpatients. A new approach in dose ranging studies

1 reference

https://api.crossref.org/works/10.1017%2FS1461145712001009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S1461145712001009

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/23067569

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48335500&oldid=1510048644"